The Olympus Blog

Medical

Minimally Invasive Solutions
Medical Technologies

When Little Things are a Big Deal: Olympus’ Investment in Eximis Aims to Keep Incisions Small

"Olympus is excited to support Eximis Surgical in the development of this promising new technology,” said Nacho Abia, Chief Strategy Officer for Olympus Corporation. “Supporting physicians in elevating the standard of care for patients is a priority for Olympus.”

Read More
Medical affairs team
At Our Core

Medical Affairs: Ready to See (and Hear) the Patient

As President (Americas Region) and Board Director of the Medical Affairs Professional Society (MAPS), John B. Pracyk, MD, PhD, MBA, Chief Medical Safety Officer, Senior Vice President, Medical & Scientific Affairs, at Olympus, provides context for how medical affairs creates and delivers value among healthcare stakeholders including physicians, providers (hospitals and health systems), payers, policymakers, and ultimately patients.

Read More
Doctor consultation
Medical Technologies

Laparoscopic Option for Live Liver Donations Offers Donor Benefits

“[Living donor hepatectomy liver transplant] is one of the most complex surgeries that can be done laparoscopically,” Dr. Kwon said in the article posted on the Cleveland Clinic site. In the U.S., laparoscopic surgery and liver transplant are two separate disciplines and few pursue both, he observed.

Read More
Medical training class
At Our Core

The Olympus Grants Program: Ready for Impact

Two notable medical education grants within the last year include a $1 million+ monetary and product donation to the American College of Chest Physicians® (CHEST) simulation center. In addition, Olympus made a first-of-its kind donation in Latin America to Asociación Mexicana de Endoscopia Gastrointestina (AMEG), a non-profit GI medical society in Mexico—to support a hands-on endoscopic training laboratory.

Read More
Professionals collaborating on a project
At Our Core

Olympus Sponsors MedTech Color 2022 Pitch Competition

On March 8, 2022, Olympus Corporation of the Americas had the honor of sponsoring a hybrid event featuring live pitches from the top 10 finalists of competing med-tech organizations all with the same goal: to get their early-stage medical technology innovation funded. The MedTech Color 2022 Pitch Competition, an inspired event via MedTech Color, served as a catalyst for early-stage med-tech companies founded or led by persons of color to present their medical innovations for awards ranging from $100K - $250K in non-dilutive funding and in-kind services. 

Read More
lung cancer screening
Medical Technologies

Lung Cancer Screenings: Raising Rates and Awareness

Lung cancer is the second most common cancer among men and women, and the leading cause of cancer death in the United States. Yet, studies show an alarmingly low rate of participation among those who are eligible for lung cancer screenings.

Read More
fibroid awareness month
Medical Technologies

Top Five Topics about Uterine Fibroids that Every Woman Should Know

July is Fibroid Awareness Month and the perfect time for women to become educated on uterine fibroids, which may be a cause of infertility.

Read More
ENDOCUFF
Research Round-Up

Prove It: The Value of Healthcare Economics in the Medical Device Industry

Olympus Director of Health Economics and Reimbursement, Beth Wall, RN, MS, shared findings of the economic value of an investment in ENDOCUFF VISION technology with the Journal of Healthcare Purchasing.

Read More
Stock image of doctor's chart
Research Round-Up

Urine Trouble: Uncovering Patient Understanding of an Enlarged Prostate

Despite the prevalence of Benign Prostatic Hyperplasia, many men lack awareness about prostate health and are reluctant to seek valuable treatment. Olympus conducted a consumer survey to learn more about their awareness and understanding.

Read More
older man with grandson
At Our Core

4 Stories That Will Change Your Mind About Avoiding Your Colonoscopy

A recent survey uncovered 4 major reasons as to why they would avoid colorectal cancer screening. As this preventable disease continues to impact our communities, Olympus is eager to dispel these common myths of colorectal cancer screenings to combat its prevalence.

Read More

Investor Information Olympus Responds to COVID-19